{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:27:03Z","timestamp":1790047623250,"version":"4.0.1"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wellbeing of Women Research","award":["RG1073"],"award-info":[{"award-number":["RG1073"]}]},{"name":"Wellbeing of Women Research","award":["RG2137"],"award-info":[{"award-number":["RG2137"]}]},{"name":"Wellbeing of Women Entry-Level Scholarship","award":["ELS706"],"award-info":[{"award-number":["ELS706"]}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V007238\/1"],"award-info":[{"award-number":["MR\/V007238\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>STUDY QUESTION<\/jats:title>\n                  <jats:p>What is the hormone receptor profile of adenomyosis lesions in comparison to correctly located endometrium?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>SUMMARY ANSWER<\/jats:title>\n                  <jats:p>Adenomyosis lesions exhibit increased oestrogen receptor (ER) expression compared to the eutopic endometrium; there are conflicting results regarding progesterone receptor (PR) expression and a lack of studies on androgen receptor (AR) expression.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                  <jats:p>Adenomyosis lesions express hormone receptors indicating an influence from ovarian steroid hormones. However, hormone treatments are often ineffective in controlling adenomyosis symptoms, which suggests alternate hormonal responses and, potentially, a distinct hormone receptor expression profile within adenomyosis lesions compared to the eutopic endometrium.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                  <jats:p>This systematic review with a thematic analysis retrieved studies from the PubMed, Ovid Medline, Embase, Scopus, and Cochrane Library databases, and searches were conducted from inception through to May 2024. Human studies were included and identified using a combination of exploded MeSH terms (\u2018adenomyosis\u2019) and free-text search terms (\u2018oestrogen receptor\u2019, \u2018progesterone receptor\u2019, \u2018androgen receptor\u2019, \u2018hormone receptor\u2019).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                  <jats:p>This review was reported in accordance with the PRISMA guidelines. All studies reporting original data concerning hormone receptors in adenomyosis lesions compared to eutopic endometrium in adenomyosis were included. Studies that did not report original data or provide a review of the field were excluded. Bias analysis was completed for each study using the Newcastle\u2013Ottawa scoring system.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                  <jats:p>There were 1905 studies identified, which were screened to include 12 studies that met the eligibility criteria, including 11 proteomic studies and one transcriptional study, with a total of 555 individual participants. ER expression was consistently increased in adenomyosis lesions compared to the eutopic endometrium, specifically in the secretory phase. When endometrial subregion was considered, this difference was specific to the endometrial functionalis only. When different isoforms were considered, this increase in ER expression was specific to ER\u03b1 rather than ER\u03b2. There were conflicting results on PR expression, with most studies showing no significant difference or reduced levels in adenomyosis lesions compared to the eutopic endometrium. There is a paucity of data on AR expression in adenomyosis lesions, with only one study of small sample size included.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                  <jats:p>A high risk of bias arose from studies grouping endometrial samples across different menstrual cycle phases for analysis. The coexistence of gynecological conditions like endometriosis may also confound the hormone receptor profile of the eutopic endometrium. Most studies employing immunostaining did not comment on region-specific differences in the endometrium. Given the well-documented cyclical variations in hormone receptor expression within the endometrium, the need for more attention to region-specific differences represents a notable limitation in the current body of literature.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                  <jats:p>The systematic review highlights oestrogen dominance through elevated ER\u03b1 levels in adenomyosis lesions, which agrees with the literature suggesting local hyper-oestrogenism in adenomyosis lesions. Heterogeneity in menstrual cycle timing and lack of endometrial region specificity prevent conclusions on progesterone resistance within adenomyosis lesions in this study. Future investigations should minimize the bias through well-defined cohorts, leading to robust exploration of hormone receptor profiles in adenomyosis lesions to identify therapeutic targets and deepen our understanding of adenomyosis pathogenesis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                  <jats:p>This work was supported by Wellbeing of Women Research Project grants RG1073 and RG2137 (D.K.H.), a Wellbeing of Women Entry-Level Scholarship ELS706 and a Medical Research Council grant MR\/V007238\/1 (A.M. and D.K.H.), as well as the University of Liverpool (L.T.). There are no conflicts of interest.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>HROPEN-24-0294.R2<\/jats:title>\n                  <jats:p>The review protocol was published in the PROSPERO Register of Systematic Reviews on 27 September 2023, registration number CRD4202346.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/hropen\/hoaf002","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:29:02Z","timestamp":1737397742000},"source":"Crossref","is-referenced-by-count":12,"title":["Hormone receptor profile of ectopic and eutopic endometrium in adenomyosis: a systematic review"],"prefix":"10.1093","volume":"2025","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5713-6959","authenticated-orcid":false,"given":"Alison","family":"Maclean","sequence":"first","affiliation":[{"name":"Department of Women\u2019s and Children\u2019s Health, Institute of Life Course and Medical Sciences, University of Liverpool , Liverpool,","place":["UK"]},{"name":"Centre for Women\u2019s Health Research, Liverpool Women\u2019s Hospital , Liverpool,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tipple","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Liverpool , Liverpool,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Newton","sequence":"additional","affiliation":[{"name":"The Hewitt Fertility Centre, Liverpool Women\u2019s NHS Foundation Trust , Knutsford,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0270-0150","authenticated-orcid":false,"given":"Dharani K","family":"Hapangama","sequence":"additional","affiliation":[{"name":"Department of Women\u2019s and Children\u2019s Health, Institute of Life Course and Medical Sciences, University of Liverpool , Liverpool,","place":["UK"]},{"name":"Centre for Women\u2019s Health Research, Liverpool Women\u2019s Hospital , Liverpool,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"2025030420165736800_hoaf002-B1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0303-7207(99)00199-9","article-title":"Expression of GnRH receptor gene in human ectopic endometrial cells and inhibition of their proliferation by leuprolide acetate","volume":"159","author":"Borroni","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"2025030420165736800_hoaf002-B2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0039-128X(03)00120-X","article-title":"A role for the androgen receptor in the endometrial antiproliferative effects of progesterone antagonists","volume":"68","author":"Brenner","year":"2003","journal-title":"Steroids"},{"key":"2025030420165736800_hoaf002-B9513432","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jpag.2014.05.008","article-title":"Uterine Cystic Adenomyosis: A Disease of Younger Women","volume":"28","author":"Brosens","year":"2015","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2025030420165736800_hoaf002-B3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.mce.2005.11.041","article-title":"Progesterone resistance in endometriosis: link to failure to metabolize estradiol","volume":"248","author":"Bulun","year":"2006","journal-title":"Mol Cell Endocrinol"},{"key":"2025030420165736800_hoaf002-B4","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.fertnstert.2023.03.006","article-title":"Endometriosis and adenomyosis: shared pathophysiology","volume":"119","author":"Bulun","year":"2023","journal-title":"Fertil Steril"},{"key":"2025030420165736800_hoaf002-B77085708","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/humrep\/dex088","article-title":"Relationship between the magnetic resonance imaging appearance of adenomyosis and endometriosis phenotypes","volume":"32","author":"Chapron","year":"2017","journal-title":"Hum Reprod"},{"key":"2025030420165736800_hoaf002-B5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/procel\/pwae012","article-title":"Comprehensive transcriptional atlas of human adenomyosis deciphered by the integration of single-cell RNA-sequencing and spatial transcriptomics","volume":"15","author":"Chen","year":"2024","journal-title":"Protein Cell"},{"key":"2025030420165736800_hoaf002-B6","first-page":"1370","article-title":"Estrogen receptor \u03b2, but not estrogen receptor \u03b1, is present in the vascular endothelium of the human and nonhuman primate endometrium","volume":"86","author":"Critchley","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2025030420165736800_hoaf002-B7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/1933719108331121","article-title":"Hormone receptor dynamics in a receptive human endometrium","volume":"16","author":"Critchley","year":"2009","journal-title":"Reprod Sci"},{"key":"2025030420165736800_hoaf002-B8","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1152\/physrev.00031.2019","article-title":"Physiology of the endometrium and regulation of menstruation","volume":"100","author":"Critchley","year":"2020","journal-title":"Physiol Rev"},{"key":"2025030420165736800_hoaf002-B9","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1007\/s40265-023-01957-7","article-title":"Current medical therapy for adenomyosis: from bench to bedside","volume":"83","author":"Etrusco","year":"2023","journal-title":"Drugs"},{"key":"2025030420165736800_hoaf002-B10","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/cjp2.83","article-title":"Isoform specificity of progesterone receptor antibodies","volume":"3","author":"Fabris","year":"2017","journal-title":"J Pathol Clin Res"},{"key":"2025030420165736800_hoaf002-B11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.fertnstert.2017.12.030","article-title":"Pathogenesis of uterine adenomyosis: invagination or metaplasia?","volume":"109","author":"Garcia-Solares","year":"2018","journal-title":"Fertil Steril"},{"key":"2025030420165736800_hoaf002-B12","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1523\/JNEUROSCI.16-11-03620.1996","article-title":"17\u03b2-Estradiol potentiates kainate-induced currents via activation of the cAMP cascade","volume":"16","author":"Gu","year":"1996","journal-title":"J Neurosci"},{"key":"2025030420165736800_hoaf002-B13","first-page":"1","volume-title":"Gynaecology by Ten Teachers","author":"Hapangama","year":"2024"},{"key":"2025030420165736800_hoaf002-B14","first-page":"149","article-title":"Mifepristone: the multifaceted antihormone","volume":"1","author":"Hapangama","year":"2003","journal-title":"J Drug Eval"},{"key":"2025030420165736800_hoaf002-B15","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/humupd\/dmu053","article-title":"Estrogen receptor \u03b2: the guardian of the endometrium","volume":"21","author":"Hapangama","year":"2015","journal-title":"Hum Reprod Update"},{"key":"2025030420165736800_hoaf002-B16","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/oxfordjournals.humrep.a137595","article-title":"Immunohistochemical localization of androgen receptor in the human endometrium, decidua, placenta and pathological conditions of the endometrium","volume":"7","author":"Horie","year":"1992","journal-title":"Hum Reprod"},{"key":"2025030420165736800_hoaf002-B17","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/254337a0","article-title":"Progesterone antagonism of the oestrogen receptor and oestrogen-induced uterine growth","volume":"254","author":"Hsueh","year":"1975","journal-title":"Nature"},{"key":"2025030420165736800_hoaf002-B18","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1038\/s41467-019-13708-y","article-title":"Uterine adenomyosis is an oligoclonal disorder associated with KRAS mutations","volume":"10","author":"Inoue","year":"2019","journal-title":"Nat Commun"},{"issue":"Suppl 1","key":"2025030420165736800_hoaf002-B19","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0015-0282(02)04813-6","article-title":"Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas","volume":"79","author":"Ishihara","year":"2003","journal-title":"Fertil Steril"},{"key":"2025030420165736800_hoaf002-B20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/er.2004-0021","article-title":"Endocrine regulation of menstruation","volume":"27","author":"Jabbour","year":"2006","journal-title":"Endocr Rev"},{"key":"2025030420165736800_hoaf002-B21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mce.2016.04.011","article-title":"The G protein-coupled estrogen receptor as a modulator of neoplastic transformation","volume":"429","author":"Jacenik","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"2025030420165736800_hoaf002-B22","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1177\/1933719110377118","article-title":"Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent","volume":"17","author":"Jichan","year":"2010","journal-title":"Reprod Sci"},{"key":"2025030420165736800_hoaf002-B23","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/bjc.2016.16","article-title":"Androgen receptors are acquired by healthy postmenopausal endometrial epithelium and their subsequent loss in endometrial cancer is associated with poor survival","volume":"114","author":"Kamal","year":"2016","journal-title":"Br J Cancer"},{"key":"2025030420165736800_hoaf002-B24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1146\/annurev.ph.42.030180.000313","article-title":"Dynamics of steroid hormone receptor action","volume":"42","author":"Katzenellenbogen","year":"1980","journal-title":"Annu Rev Physiol"},{"key":"2025030420165736800_hoaf002-B25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejogrb.2016.05.012","article-title":"Biological differences between functionalis and basalis endometria in women with and without adenomyosis","volume":"203","author":"Khan","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025030420165736800_hoaf002-B26","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1093\/humrep\/deq240","article-title":"Cell proliferation effect of GnRH agonist on pathological lesions of women with endometriosis, adenomyosis and uterine myoma","volume":"25","author":"Khan","year":"2010","journal-title":"Hum Reprod"},{"key":"2025030420165736800_hoaf002-B27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/humrep\/16.1.51","article-title":"Oestrogen receptor-alpha gene polymorphism is associated with endometriosis, adenomyosis and leiomyomata","volume":"16","author":"Kitawaki","year":"2001","journal-title":"Hum Reprod"},{"key":"2025030420165736800_hoaf002-B28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1093\/molehr\/gaq043","article-title":"G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua","volume":"16","author":"Kolkova","year":"2010","journal-title":"Mol Hum Reprod"},{"key":"2025030420165736800_hoaf002-B29","first-page":"93","article-title":"Changes in the concentrations of receptors of insulin-like growth factor-I, epithelial growth factor, oestrogens and progestagens in adenomyosis foci, endometrium and myometrium of women during menstrual cycle","volume":"19","author":"Konopka","year":"1998","journal-title":"Eur J Gynaecol Oncol"},{"key":"2025030420165736800_hoaf002-B30","first-page":"1379","article-title":"Presence of estrogen receptor beta in the human endometrium through the cycle: expression in glandular, stromal, and vascular cells","volume":"86","author":"Lecce","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2025030420165736800_hoaf002-B31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1515\/HMBCI.2011.002","article-title":"A new concept of endometriosis and adenomyosis: tissue injury and repair (TIAR)","volume":"5","author":"Leyendecker","year":"2011","journal-title":"Horm Mol Biol Clin Investig"},{"key":"2025030420165736800_hoaf002-B32","doi-asserted-by":"crossref","first-page":"101761","DOI":"10.1016\/j.jogoh.2020.101761","article-title":"Dysmenorrhea in patients with adenomyosis: a clinical and demographic study","volume":"50","author":"Li","year":"2021","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"2025030420165736800_hoaf002-B33","doi-asserted-by":"crossref","first-page":"103925","DOI":"10.1016\/j.jri.2023.103925","article-title":"Characterising the immune cell phenotype of ectopic adenomyosis lesions compared with eutopic endometrium: a systematic review","volume":"157","author":"Maclean","year":"2023","journal-title":"J Reprod Immunol"},{"key":"2025030420165736800_hoaf002-B34","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/humrep\/deaa177","article-title":"Fallopian tube epithelial cells express androgen receptor and have a distinct hormonal responsiveness when compared with endometrial epithelium","volume":"35","author":"Maclean","year":"2020","journal-title":"Hum Reprod"},{"key":"2025030420165736800_hoaf002-B35","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1158\/0008-5472.CAN-10-0408","article-title":"Nuclear alternate estrogen receptor GPR30 mediates 17\u03b2-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts","volume":"70","author":"Madeo","year":"2010","journal-title":"Cancer Res"},{"key":"2025030420165736800_hoaf002-B36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/humupd\/dmv059","article-title":"GnRH and GnRH receptors in the pathophysiology of the human female reproductive system","volume":"22","author":"Maggi","year":"2016","journal-title":"Hum Reprod Update"},{"key":"2025030420165736800_hoaf002-B37","doi-asserted-by":"crossref","first-page":"E1746","DOI":"10.1210\/jc.2011-0272","article-title":"In silico analysis identifies a novel role for androgens in the regulation of human endometrial apoptosis","volume":"96","author":"Marshall","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2025030420165736800_hoaf002-B38","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.fertnstert.2011.02.051","article-title":"Estrogen and progesterone receptor isoform distribution through the menstrual cycle in uteri with and without adenomyosis","volume":"95","author":"Mehasseb","year":"2011","journal-title":"Fertil Steril"},{"key":"2025030420165736800_hoaf002-B39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0301-2115(00)00554-6","article-title":"Androgen, estrogen and progesterone receptor expression in the human uterus during the menstrual cycle","volume":"98","author":"Mertens","year":"2001","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2025030420165736800_hoaf002-B40","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/00003081-198812000-00008","article-title":"Treatment of endometriosis with estrogen-progestin combination and progestogens alone","volume":"31","author":"Moghissi","year":"1988","journal-title":"Clin Obstet Gynecol"},{"key":"2025030420165736800_hoaf002-B41","first-page":"2963","article-title":"Colocalization of progesterone receptors A and B by dual immunofluorescent histochemistry in human endometrium during the menstrual cycle","volume":"84","author":"Mote","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2025030420165736800_hoaf002-B42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.acthis.2004.02.005","article-title":"Immunohistochemical analysis of estrogen receptor alpha, estrogen receptor beta and progesterone receptor in normal human endometrium","volume":"106","author":"Mylonas","year":"2004","journal-title":"Acta Histochem"},{"key":"2025030420165736800_hoaf002-B43","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.fertnstert.2009.01.084","article-title":"Immunoreactivity of progesterone receptor isoform B, nuclear factor \u03baB, and I\u03baB\u03b1 in adenomyosis","volume":"92","author":"Nie","year":"2009","journal-title":"Fertil Steril"},{"key":"2025030420165736800_hoaf002-B44","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/molehr\/gah113","article-title":"Functional characterization of somatic point mutations of the human estrogen receptor alpha (hER\u03b1) in adenomyosis uteri","volume":"10","author":"Oehler","year":"2004","journal-title":"Mol Hum Reprod"},{"key":"2025030420165736800_hoaf002-B45","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"2025030420165736800_hoaf002-B46","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"2025030420165736800_hoaf002-B47","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/igc.0000000000001121","article-title":"Assessing estrogen-induced proliferative response in an endometrial cancer cell line using a universally applicable methodological guide","volume":"28","author":"Parkes","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"2025030420165736800_hoaf002-B48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/humupd\/dmu056","article-title":"Role of nuclear progesterone receptor isoforms in uterine pathophysiology","volume":"21","author":"Patel","year":"2015","journal-title":"Hum Reprod Update"},{"key":"2025030420165736800_hoaf002-B49","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1177\/1933719111431000","article-title":"G protein-coupled estrogen receptor (GPER) expression in normal and abnormal endometrium","volume":"19","author":"Plante","year":"2012","journal-title":"Reprod Sci"},{"key":"2025030420165736800_hoaf002-B50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1095\/biolreprod59.3.661","article-title":"Quantitative gonadotropin-releasing hormone gene expression and immunohistochemical localization in human endometrium throughout the menstrual cycle","volume":"59","author":"Raga","year":"1998","journal-title":"Biol Reprod"},{"key":"2025030420165736800_hoaf002-B51","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1126\/science.1106943","article-title":"A transmembrane intracellular estrogen receptor mediates rapid cell signaling","volume":"307","author":"Revankar","year":"2005","journal-title":"Science"},{"key":"2025030420165736800_hoaf002-B52","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fphar.2016.00030","article-title":"The important roles of steroid sulfatase and sulfotransferases in gynecological diseases","volume":"7","author":"Rizner","year":"2016","journal-title":"Front Pharmacol"},{"key":"2025030420165736800_hoaf002-B53","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13669-022-00326-7","article-title":"Mechanisms and pathogenesis of adenomyosis","volume":"11","author":"Rossi","year":"2022","journal-title":"Curr Obstet Gynecol Rep"},{"key":"2025030420165736800_hoaf002-B54","doi-asserted-by":"crossref","first-page":"103795","DOI":"10.1016\/j.jri.2023.103795","article-title":"The immunohistochemical expression of GPER and classical sex hormone receptors differs in adenomyosis and eutopic endometrium","volume":"156","author":"Samartzis","year":"2023","journal-title":"J Reprod Immunol"},{"key":"2025030420165736800_hoaf002-B55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1477-7827-10-30","article-title":"Expression of the G protein-coupled estrogen receptor (GPER) in endometriosis: a tissue microarray study","volume":"10","author":"Samartzis","year":"2012","journal-title":"Reprod Biol Endocrinol"},{"key":"2025030420165736800_hoaf002-B56","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1128\/MCB.21.18.6122-6131.2001","article-title":"Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294","volume":"21","author":"Shen","year":"2001","journal-title":"Mol Cell Biol"},{"key":"2025030420165736800_hoaf002-B57","first-page":"24","article-title":"Comprehensive RNA sequencing of healthy human endometrium at two time points of the menstrual cycle","volume":"96","author":"Sigurgeirsson","year":"2017","journal-title":"Biol Reprod"},{"key":"2025030420165736800_hoaf002-B58","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0021-9258(18)52466-2","article-title":"Transcriptional activation and nuclear targeting signals of the human androgen receptor","volume":"266","author":"Simental","year":"1991","journal-title":"J Biol Chem"},{"key":"2025030420165736800_hoaf002-B59","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1679\/aohc.67.393","article-title":"Hormonal regulation and localization of estrogen, progestin and androgen receptors in the endometrium of nonhuman primates: effects of progesterone receptor antagonists","volume":"67","author":"Slayden","year":"2004","journal-title":"Arch Histol Cytol"},{"key":"2025030420165736800_hoaf002-B60","first-page":"2668","article-title":"Progesterone antagonists increase androgen receptor expression in the rhesus macaque and human endometrium","volume":"86","author":"Slayden","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2025030420165736800_hoaf002-B61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/jrf.0.0940363","article-title":"Immunocytochemical analysis of oestrogen receptors and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause","volume":"94","author":"Snijders","year":"1992","journal-title":"J Reprod Fertil"},{"key":"2025030420165736800_hoaf002-B62","doi-asserted-by":"crossref","first-page":"4407","DOI":"10.3390\/jcm11154407","article-title":"Functional Implications of Estrogen and Progesterone Receptors Expression in Adenomyosis, Potential Targets for Endocrinological Therapy","volume":"11","author":"Sztachelska","year":"2022","journal-title":"J Clin Med"},{"key":"2025030420165736800_hoaf002-B63","first-page":"1849","article-title":"Clinical usefulness of determination of estradiol level in the menstrual blood for patients with endometriosis","volume":"41","author":"Takahashi","year":"1989","journal-title":"Nihon Sanka Fujinka Gakkai Zasshi"},{"key":"2025030420165736800_hoaf002-B64","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0015-0282(16)43935-X","article-title":"Steroid receptor levels and histology of endometriosis and adenomyosis","volume":"31","author":"Tamaya","year":"1979","journal-title":"Fertil Steril"},{"key":"2025030420165736800_hoaf002-B65","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/01.pgp.0000130109.80359.57","article-title":"Expression of apoptosis-related proteins in adenomyotic uteri treated with danazol and GnRH agonists","volume":"23","author":"Ueki","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"2025030420165736800_hoaf002-B66","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.rbmo.2017.06.016","article-title":"Pathogenesis of adenomyosis: an update on molecular mechanisms","volume":"35","author":"Vannuccini","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"2025030420165736800_hoaf002-B67","author":"Wells","year":"2013"},{"key":"2025030420165736800_hoaf002-B68","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1177\/002215540305100808","article-title":"Membrane-bound progesterone receptor expression in human aortic endothelial cells","volume":"51","author":"Welter","year":"2003","journal-title":"J Histochem Cytochem"},{"key":"2025030420165736800_hoaf002-B69","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/humupd\/4.4.323","article-title":"Surgical and medical treatment of adenomyosis","volume":"4","author":"Wood","year":"1998","journal-title":"Hum Reprod Update"},{"key":"2025030420165736800_hoaf002-B70","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1095\/biolreprod.114.127324","article-title":"Gonadotropin-releasing hormone type II (GnRH-II) agonist regulates the motility of human decidual endometrial stromal cells: possible effect on embryo implantation and pregnancy","volume":"92","author":"Wu","year":"2015","journal-title":"Biol Reprod"},{"key":"2025030420165736800_hoaf002-B71","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.fertnstert.2023.01.041","article-title":"Adenomyosis: single-cell transcriptomic analysis reveals a paracrine mesenchymal-epithelial interaction involving the WNT\/SFRP pathway","volume":"119","author":"Yildiz","year":"2023","journal-title":"Fertil Steril"},{"key":"2025030420165736800_hoaf002-B72","doi-asserted-by":"crossref","first-page":"827724","DOI":"10.3389\/fendo.2022.827724","article-title":"Estrogen receptor function: impact on the human endometrium","volume":"13","author":"Yu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025030420165736800_hoaf002-B73","first-page":"383","article-title":"[Role of estrogen, estrogen receptors, and aromatase in the pathogenesis of uterine adenomyosis]","volume":"37","author":"Zeng","year":"2017","journal-title":"Nan Fang Yi Ke Da Xue Bao"},{"key":"2025030420165736800_hoaf002-B74","first-page":"210","article-title":"The expression of the receptors of estrogen, progesterone, epidermal growth factor and growth hormone in uterine adenomyosis and a comparative study after treatment with androgen","volume":"34","author":"Zhang","year":"1999","journal-title":"Zhonghua Fu Chan Ke Za Zhi"},{"key":"2025030420165736800_hoaf002-B75","first-page":"417","article-title":"Expression and significance of Ki-67, ER and PR in adenomyosis","volume":"30","author":"Zhang","year":"2008","journal-title":"J Dalian Med Univ"},{"key":"2025030420165736800_hoaf002-B76","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1042\/CS20160114","article-title":"GPER-novel membrane oestrogen receptor","volume":"130","author":"Zimmerman","year":"2016","journal-title":"Clin Sci (Lond)"}],"container-title":["Human Reproduction Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/hropen\/advance-article-pdf\/doi\/10.1093\/hropen\/hoaf002\/61520743\/hoaf002.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hropen\/article-pdf\/2025\/1\/hoaf002\/61520743\/hoaf002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/hropen\/article-pdf\/2025\/1\/hoaf002\/61520743\/hoaf002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,4]],"date-time":"2025-03-04T21:29:03Z","timestamp":1741123743000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hropen\/article\/doi\/10.1093\/hropen\/hoaf002\/7964727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1,3]]}},"URL":"https:\/\/doi.org\/10.1093\/hropen\/hoaf002","relation":{},"ISSN":["2399-3529"],"issn-type":[{"value":"2399-3529","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025]]},"published":{"date-parts":[[2025]]},"article-number":"hoaf002"}}